Betul Balaban Kocas, Kadriye Kilickesmez

Department of Cardiology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey

Keywords: Catheter-directed thrombolysis, COVID-19, pulmonary embolism


Since December 2019, the novel coronavirus (COVID-19) outbreak has become an important public health problem and one of the most common causes of morbidity and mortality worldwide. COVID-19 is highly associated with thromboembolic events, like deep venous thrombosis and pulmonary embolism (PE). Catheter-directed thrombolysis (CDT) provides effective reperfusion for the treatment of PE. We report a patient who was presented with intermediate-risk PE and had a saccular aneurysm of the anterior cerebral artery. The patient was suffered from recent COVID-19 infection and ischemic stroke. As the patient had high bleeding risk for full-dose systemic thrombolytic therapy, CDT was the preferred method for reperfusion. Finally, the patient was discharged from the hospital uneventfully 4 days later. In the setting of high bleeding risk, CDT seems to be an effective and safe approach in patients with intermediate-risk PE.

Author Contributions

Concept B.B.K.; Design B.B.K., K.K.; Supervision K.K.; Materials –B.B.K., K.K.; Data collection and/or processing – B.B.K., K.K.; Analysis and/or interpretation – B.B.K., Literature search – B.B.K., K.K.; Writing B.B.K.; Critical revision K.K.

Conflict of Interest

None Declared.

Financial Disclosure